阴虚胃痛胶囊治疗胃癌前病变机制的网络药理学与实验验证
本研究旨在评估阴虚胃痛胶囊(YXWTC)对胃癌前病变(PLGC)的作用及机制。采用UHPLC-ESI-QE-Orbitrap-MS鉴定出340种成分,建立PLGC大鼠模型,通过网络药理学和分子对接预测靶点,并结合多种实验验证。结果表明YXWTC可改善胃黏膜病理,其作用与抑制IL-6/STAT3通路、促进线粒体凋亡和诱导ROS释放相关。
要点
- 阴虚胃痛胶囊可改善PLGC大鼠胃黏膜病理。
- 其机制涉及抑制IL-6/STAT3通路、促进线粒体凋亡和ROS释放。
- 网络药理学鉴定出340种成分和403个PLGC相关共同靶点。
核心结论
- 阴虚胃痛胶囊对胃癌前病变具有保护作用,其机制与抑制IL-6/STAT3通路、促进线粒体凋亡和诱导ROS释放有关。
研究设计与样本
- 采用UHPLC-ESI-QE-Orbitrap-MS鉴定YXWTC成分。
- 建立PLGC动物模型,使用H&E、AB-PAS、AB-HID染色和TEM评估胃黏膜保护作用,H&E染色评估生物安全性。
- 通过网络药理学和分子对接预测靶点,并用ELISA、RT-qPCR、Western blotting、免疫组化、凋亡检测和ROS荧光染色验证机制。
主要发现
- 共鉴定出340种YXWTC成分。
- YXWTC有效改善PLGC大鼠胃黏膜病理。
- 网络药理学识别出403个PLGC与YXWTC共同靶点,GO分析得到2323个生物学过程,KEGG分析得到206条信号通路。
- 分子对接显示主要靶蛋白与主要药物分子具有强结合亲和力。
- 动物实验表明YXWTC抑制IL-6/STAT3通路,促进线粒体凋亡,诱导ROS释放。
临床怎么用
- 阴虚胃痛胶囊可能作为胃癌前病变的潜在治疗选择,其作用机制涉及IL-6/STAT3通路、线粒体凋亡和ROS释放。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Yinxu Weitong Capsule (YXWTC) is a Chinese patent medicine used to treat chronic gastritis. However, its efficacy and mechanisms of action in treating precancerous lesions of gastric cancer (PLGC) remain unclear. AIM OF THE STUDY: To evaluate the effects of YXWTC on PLGC and explore the underlying mechanisms. MATERIALS AND METHODS: YXWTC components were identified using ultra-high-performance liquid chromatography coupled with electrospray ionization quadrupole-exactive orbitrap mass spectrometry. A PLGC animal model was established and the protective effects of YXWTC on the gastric mucosa in PLGC rats were evaluated using hematoxylin and eosin (H&E), Alcian blue-periodic acid-Schiff and Alcian blue-high iron diamine staining, and transmission electron microscopy (TEM). The vital organs of the rats were examined using H&E staining to evaluate biosafety. Network pharmacology identified potential targets and pathways of YXWTC in PLGC treatment, followed by molecular docking validation. Various techniques, including enzyme-linked immunosorbent assay, real-time quantitative reverse transcription PCR, Western blotting, immunohistochemistry, apoptosis detection, and reactive oxygen species fluorescence staining were employed to elucidate the underlying mechanisms. RESULTS: In total, 340 YXWTC components were identified. YXWTC effectively improves gastric mucosal pathology in rats with PLGC. Network pharmacology identified 403 targets common to PLGC and YXWTC. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses identified 2,323 biological processes and 206 signaling pathways, respectively. Molecular docking revealed that the primary target proteins and major drug molecules exhibited strong binding affinities. Animal studies demonstrated that YXWTC inhibited the IL-6/STAT3 pathway, promoted mitochondrial apoptosis, and induced ROS release. CONCLUSIONS: We verified the pharmacodynamic effects of YXWTC in PLGC. In summary, the effects are mediated by inhibition of the IL-6/STAT3 pathway, promotion of mitochondrial apoptosis, and induction of ROS release.
引用
- Wang Y, Li D, Zhao L, et al. Mechanism of Yinxu Weitong Capsule in the treatment of precancerous lesions of gastric cancer based on network pharmacology and experimental validation. J Ethnopharmacol. 2025. PMID: 39761837. doi:10.1016/j.jep.2024.119303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。